CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call
16 mars 2023 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative...
CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial
21 févr. 2023 07h00 HE
|
CVRx, Inc.
MINNEAPOLIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative...
CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
26 janv. 2023 16h15 HE
|
CVRx, Inc.
MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023
12 janv. 2023 17h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results
09 janv. 2023 08h45 HE
|
CVRx, Inc.
MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
28 déc. 2022 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Dec. 28, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors
20 déc. 2022 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative...
CVRx to Present at the Piper Sandler 34th Annual Healthcare Conference
16 nov. 2022 08h00 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 16, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Launches new Barostim NEO2™ Implantable Pulse Generator
03 nov. 2022 10h31 HE
|
CVRx, Inc.
The new Barostim NEO2 Implantable Pulse Generator (IPG) launches in the U.S., improving the patient experience while on therapy and simplifying the implant procedure for physicians MINNEAPOLIS, Nov. ...
CVRx to Attend Upcoming Investor Conferences
03 nov. 2022 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...